Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, open-label study of the effect of MabThera, with and without fludarabine/cyclophosphamide, on progression-free survival in patients with chronic lymphocytic leukemia
Rituximab
ML17102
NCT00281918
lymphoid leukaemia
Phase 3
 
October 2015

Powered by ideaPoint, Inc.